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Résumé en
anglais
It is now well established that gut flora and chronic liver diseases are closely
interrelated. This association is most evident at late stages of the disease: cirrhosis
and impaired liver function are associated with intestinal bacterial overgrowth,
small bowel dysmotility, increased gut permeability, and decreased immunological
defenses, all of which promote bacterial translocation from the gut to the systemic
circulation, leading to infections that in turn aggravate liver dysfunction in a
vicious circle [1]. For a long time, the implication of gut flora in the
pathophysiology of less advanced chronic liver diseases has been underestimated
because technical limitations allow only for the culture of a small fraction of gut
bacteria. Recent technological progress and next-generation DNA sequencing have
allowed for more sophisticated analysis and sampling of the gut microbiota by
culture-independent methods [2]. Thanks to these recent technological advances,
knowledge about the role of gut microbiota disruption (dysbiosis) in gut diseases
such as colon cancer, inflammatory bowel diseases, and irritable bowel syndrome
has greatly increased, with possible new therapeutic strategies. More surprisingly,
gut dysbiosis has been implicated in chronic metabolic disorders such as obesity,
metabolic syndrome, diabetes, and cardiovascular diseases [3]. Nonalcoholic fatty
liver disease (NAFLD) is the liver manifestation of the metabolic syndrome and thus
evolves in the same context as these metabolic diseases [4]. It is therefore not
surprising that recent literature emphasizes a potential role for gut dysbiosis in the
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